Equitec Proprietary Markets, LLC Xencor Inc Transaction History

Equitec Proprietary Markets, LLC

  • $196 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021
SELL
$34.33 - $44.68 $5,218 - $6,791
-152 Closed
0 $0
Q4 2020

Jan 26, 2021
BUY
$36.63 - $47.63 $5,567 - $7,239
152 New
152 $7,000
Q3 2020

Oct 13, 2020
SELL
$30.09 - $43.02 $30,090 - $43,020
-1,000 Closed
0 $0
Q1 2020

Apr 19, 2021
BUY
$20.69 - $37.79 $20,690 - $37,790
1,000 New
1,000 $43,000

Others Institutions Holding XNCR

# of Institutions
199
Shares Held
73.7M
Call Options Held
1.7K
Put Options Held
4.2K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $579M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email